Top compounds associated with response to YPEL1

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	nelarabine	CTRPv2	pan-cancer	AAC	0.48	5e-33
mRNA	UNC0638:navitoclax (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.34	1e-19
mRNA	GSK1070916	GDSC1000	pan-cancer	AAC	0.3	8e-19
mRNA	ABT-263	CTRPv2	pan-cancer	AAC	0.32	2e-18
mRNA	carboplatin:etoposide (40:17 mol/mol)	CTRPv2	pan-cancer	AAC	0.27	4e-18
mRNA	barasertib	CTRPv2	pan-cancer	AAC	0.29	9e-18
mRNA	PX-12	CTRPv2	pan-cancer	AAC	0.26	2e-17
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.27	9e-17
mRNA	Cytarabine	CTRPv2	pan-cancer	AAC	0.23	2e-14
mRNA	bendamustine	CTRPv2	pan-cancer	AAC	0.3	3e-14

Download CSV